Most pipeline reviews are status updates dressed up as strategy sessions. Here's how to run deal reviews that diagnose the real problem and actually move stuck deals forward.
There's a pattern that plays out in almost every pipeline review. The rep describes the deal. Leadership asks the standard questions. The rep explains what they're planning to do. A few suggestions get offered. Everyone moves to the next item. And nothing changes, the deal stays stuck.
The problem isn't the people in the room. It's the structure of the review itself. A deal review built around status updates, 'where is it?' rather than 'what's blocking it and what are we going to do about it?', generates information without action. The deal gets discussed. It doesn't get diagnosed. It receives attention but no real intervention.
This article gives you a practical approach to deal reviews that actually move stuck opportunities, built around four connected disciplines that most teams treat as separate rather than sequential. There are no phase labels or process stages here, just the logic of what good deal reviews actually do and how to run one.
Most deal reviews are run as reporting sessions. They should be run as intervention sessions. The distinction sounds small, it produces completely different outcomes.
A deal review has two jobs: identify the specific blocker preventing a deal from advancing, and agree on a specific intervention that addresses it. Everything else- the deal history, the relationship summary, the rep's confidence level is context. It's worth knowing, but it's not the point. If the review ends without a clear blocker named and a clear intervention assigned, the review didn't accomplish its purpose.
The diagnostic question that should anchor every deal review: 'Why hasn't this deal advanced in the last 14 days, and what specifically would need to be true for it to advance in the next 14?' That question forces both the rep and the manager to think in terms of specific blockers and specific actions, rather than general optimism or general concern. It's a different kind of conversation,, and it produces a different kind of outcome.
The quality of a deal review is determined before it starts. Most reps arrive with a story. The best ones arrive with a diagnosis because they've reviewed the right data before the meeting begins.
Before any deal review, both the rep and the manager should independently pull three things: the deal's stage history (how long has it been in the current stage, and what happened at the last stage transition?), the engagement history (when did the prospect last respond, and what was the nature of that response?), and the qualification status (which criteria were confirmed in discovery, and are any of them now in question?).
The difference this makes in practice is significant. A manager who walks in knowing that a deal has been in proposal for 28 days with no prospect response asks completely different questions than one walking in cold. 'This deal has been in proposal for 28 days with no response' is a diagnostic starting point. 'How's the ABC deal going?' is an invitation for a status update. One leads to a real conversation. The other leads to the meeting that does not move.
These five points take about ten minutes to review and transform the quality of everything that follows. None of them require a complex report; they're all available in a standard CRM view.
The diagnostic part of the review is where most deal reviews fail. They identify the symptom, the prospect hasn't responded, without identifying the cause, why they haven't responded, and what would actually change that.
Effective deal diagnosis requires asking 'why' at least twice. The first 'why' surfaces the proximate cause. The second surfaces the underlying cause. The underlying cause is where the intervention needs to happen because fixing the proximate cause without addressing the underlying one just delays the next stall.
A concrete example: the prospect hasn't responded to the last three follow-ups. Why? Because they said they needed to loop in their CFO. Why hasn't that happened? Because the champion doesn't have a business case document that makes the financial argument the CFO needs to see. The intervention isn't another follow-up email; it's building the CFO business case and giving the champion the tool they need to get internal alignment. The follow-up email addresses the symptom. The business case addresses the cause.
Asked in sequence, these four questions take a deal review from status update to actionable diagnosis. Each one builds on the previous, narrowing from 'what's happening' to 'what needs to happen and who needs to do it.'
Question 1: 'What specifically is preventing this deal from moving to the next stage right now?' Push for a specific answer, not 'they're evaluating' but 'they haven't confirmed budget' or 'the champion is waiting for sign-off from a stakeholder we haven't met.'
Question 2: 'What does the prospect need to have, know, or believe to move forward?' This question shifts the frame from what the rep needs (a response) to what the buyer needs (information, permission, a tool, an answer). That shift is where most deal reviews fail to go.
Question 3: 'What have we done to help them get there, and is there something we haven't done that we should?' This surfaces gaps in the rep's approach without framing it as a performance critique. It's diagnostic, not evaluative, which makes it more likely to produce honest answers.
Question 4: 'If this deal closes, what will we point to as the thing that moved it? If it dies, what will we say we should have done differently?' Asking about the outcome in advance before it's determined often surfaces the intervention that's been missing more reliably than any other question.
Identifying the blocker is only valuable if it produces a specific intervention. This is where most deal reviews stop short; they get to the diagnosis and then assign the solution as homework rather than building it in the room.
An intervention is not 'follow up more aggressively' or 'try to get a meeting.' Those are activities, not interventions. An intervention is a specific action that addresses the specific blocker identified in the diagnostic conversation. The champion doesn't have a business case? Build one, right now, in this meeting, and give it to the rep to deliver today. Hasn't the decision-maker been involved? Draft an executive introduction request together before leaving the room. The buying process hasn't been mapped? Give the rep the exact question to ask on their next call.
The reason interventions need to be built in the session rather than assigned afterward is simple: tasks assigned at the end of a meeting compete with everything else on the rep's plate. The intervention that would save a deal is rarely urgent enough to win that competition. When it gets built in the room, it gets done. When it gets assigned as a follow-up, it usually doesn't.
Most stuck deals respond to one of three interventions. Knowing which one to apply is the direct output of a good diagnostic conversation, which is why the diagnosis has to come first.
Champion enablement addresses stalls caused by internal alignment problems. The champion needs something to sell internally: a business case, a competitive comparison, a security overview, an executive summary. Build it together in the review and give it to the rep to deliver the same day. A champion who has the right tool to make the internal case is a champion who can actually advance the deal.
Stakeholder expansion addresses stalls caused by a qualification gap around authority. A decision-maker or budget owner hasn't been in the conversation. The intervention is an executive introduction, a manager or executive from the selling side reaching out directly to the equivalent level on the buying side. This works because it creates a peer-to-peer relationship that bypasses the single-threaded dynamic that was stalling the deal.
Urgency creation addresses stalls caused by a missing urgency case. The deal is drifting because there's no internal pressure to move. The intervention is a discovery-style conversation about consequences, asking the champion directly what happens for their team if this doesn't get resolved this quarter. Urgency that the buyer has articulated in their own words creates the internal pressure that moves deals; urgency imposed by the seller creates resistance.
The accountability check-in is the most consistently skipped part of deal review practice, and the part that determines whether the intervention from the review actually happens or quietly gets deprioritized when the week fills up.
The check-in is not another deal review. It's a 10-minute conversation, five to seven business days after the review, with a single agenda item: did the intervention happen, and what was the result? Not how is the deal going; that's a different conversation. Did the business case document get sent? Did the executive introduction happen? Did the urgency conversation take place? The intervention is what moves the deal. The check-in is what ensures the intervention happens.
A deal review without an accountability check-in is a diagnosis without treatment. The diagnosis might be correct. Without follow-through on the intervention, the outcome doesn't change. Which means the review consumed management time and rep attention, produced a clear plan, and then produced no results because the plan never got executed.
The check-in will sometimes reveal that the intervention wasn't completed. The right question isn't why, it's what's the fastest path to making it happen now.
Sometimes the obstacle is practical: the champion wasn't available, the business case required input the rep didn't have, the executive introduction needed a relationship that wasn't directly accessible. These are solvable with help, and the check-in is exactly the moment to provide it. Sometimes the obstacle is motivational: the rep doesn't actually believe the deal is winnable and is unconsciously deprioritizing it. That's a different conversation, about deal qualification rather than deal strategy.
Either way, a deal that hasn't received its intervention within seven days of the review needs to be triaged. The intervention happens immediately, or the deal gets moved to a lower pipeline priority. Allowing a deal to sit in the active pipeline while its intervention stays incomplete is the worst of both worlds; it consumes attention without moving, and it distorts forecast accuracy in the process.
A deal review process that runs only when someone escalates isn't a process. It's a fire drill. The structure needs to be built into the regular management cadence so that stuck deals get systematic attention rather than ad hoc attention.
A weekly 1:1 between a manager and a rep should include a standing agenda item: one stuck deal, reviewed with the full diagnostic structure. Not every deal, every week, one deal, done properly. Over a quarter, every deal in the pipeline will have received at least one structured review. The manager will have a current, data-grounded picture of every opportunity's real health, rather than the optimistic narrative the rep presents when no one's asking hard questions.
Most deal reviews are designed to give leadership visibility into the pipeline. The problem is that visibility without intervention doesn't move deals; it just describes where they're stuck in greater detail.
The structure above- preparation, diagnosis, intervention, accountability is designed to produce a single outcome: a specific deal moved forward in a specific way, with specific ownership and a specific follow-up. Every element serves that purpose. The preparation prevents the review from starting with the wrong frame. The diagnosis surfaces the real blocker rather than the proximate cause. The intervention builds the specific action in the room rather than assigning it as homework. The accountability check-in ensures the intervention actually gets done.
Run this structure consistently, and your deal reviews stop being the place where stuck deals get described. They become the place where stuck deals get unstuck.
A deal review that ends without a specific intervention assigned to a specific person with a specific deadline didn't do its job. The conversation was good. The outcome wasn't.
